Lise Aagaard

1.5k total citations
41 papers, 1.0k citations indexed

About

Lise Aagaard is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Lise Aagaard has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Toxicology, 15 papers in Pediatrics, Perinatology and Child Health and 11 papers in Economics and Econometrics. Recurrent topics in Lise Aagaard's work include Pharmacovigilance and Adverse Drug Reactions (17 papers), Pharmaceutical studies and practices (15 papers) and Pharmaceutical Economics and Policy (11 papers). Lise Aagaard is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (17 papers), Pharmaceutical studies and practices (15 papers) and Pharmaceutical Economics and Policy (11 papers). Lise Aagaard collaborates with scholars based in Denmark, United States and Sweden. Lise Aagaard's co-authors include Ebba Holme Hansen, Johanna Strandell, Lars Nielsen, Mike Strauss, Jiří Lukáš, Jiří Bártek, Lars Juhl Jensen, Gerd Glaeske, Julie M. Zito and Irene Petersen and has published in prestigious journals such as PLoS ONE, Social Science & Medicine and BMJ.

In The Last Decade

Lise Aagaard

41 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lise Aagaard Denmark 17 383 258 165 158 154 41 1.0k
Julien Bezin France 18 122 0.3× 109 0.4× 126 0.8× 107 0.7× 175 1.1× 67 1.2k
Tom Mjörndal Sweden 23 423 1.1× 325 1.3× 493 3.0× 236 1.5× 189 1.2× 59 2.0k
Elliot G. Brown United Kingdom 5 494 1.3× 185 0.7× 81 0.5× 231 1.5× 103 0.7× 11 1.3k
Sue Wood United States 6 326 0.9× 137 0.5× 66 0.4× 172 1.1× 58 0.4× 14 1.1k
James P. Wilson United States 15 82 0.2× 145 0.6× 245 1.5× 59 0.4× 193 1.3× 31 1.2k
Lolkje de Jong‐van den Berg Netherlands 14 347 0.9× 522 2.0× 141 0.9× 91 0.6× 138 0.9× 28 1.1k
Faizan Mazhar Sweden 18 83 0.2× 105 0.4× 133 0.8× 84 0.5× 68 0.4× 64 964
Emmanuelle Bondon‐Guitton France 17 178 0.5× 122 0.5× 98 0.6× 148 0.9× 35 0.2× 44 834
Linda Härmark Netherlands 23 812 2.1× 325 1.3× 58 0.4× 286 1.8× 297 1.9× 59 1.4k
Anneke Passier Netherlands 14 320 0.8× 359 1.4× 41 0.2× 98 0.6× 140 0.9× 26 1.1k

Countries citing papers authored by Lise Aagaard

Since Specialization
Citations

This map shows the geographic impact of Lise Aagaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise Aagaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise Aagaard more than expected).

Fields of papers citing papers by Lise Aagaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lise Aagaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise Aagaard. The network helps show where Lise Aagaard may publish in the future.

Co-authorship network of co-authors of Lise Aagaard

This figure shows the co-authorship network connecting the top 25 collaborators of Lise Aagaard. A scholar is included among the top collaborators of Lise Aagaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lise Aagaard. Lise Aagaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aagaard, Lise. (2020). Marketing of healthcare services in Denmark: the concept of misleading advertising. International Journal of Clinical Pharmacy. 42(6). 1524–1527. 4 indexed citations
2.
Jørgensen, Marit E., et al.. (2017). Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation. PLoS ONE. 12(6). e0179546–e0179546. 22 indexed citations
3.
Thomsen, Per Hove, Søren Dalsgaard, Ebba Holme Hansen, et al.. (2016). Switch in Therapy from Methylphenidate to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Analysis of Patient Records. Journal of Child and Adolescent Psychopharmacology. 26(4). 354–361. 7 indexed citations
4.
Bachmann, Christian, Lise Aagaard, Mehmet Burcu, et al.. (2016). Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012. European Neuropsychopharmacology. 26(3). 411–419. 127 indexed citations
5.
Aagaard, Lise, Henrik U. Andersen, Søren Brunak, et al.. (2015). Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicines. Journal of Research in Pharmacy Practice. 4(2). 64–64. 6 indexed citations
6.
Pottegård, Anton, Tore Bjerregaard Stage, Morten Hansen, et al.. (2014). SearCh for humourIstic and Extravagant acroNyms and Thoroughly Inappropriate names For Important Clinical trials (SCIENTIFIC): qualitative and quantitative systematic study. BMJ. 349(dec16 13). g7092–g7092. 8 indexed citations
7.
8.
Jørgensen, Marit E., et al.. (2014). A Multistate Model and an Algorithm for Measuring Long-Term Adherence to Medication: A Case of Diabetes Mellitus Type 2. Value in Health. 17(2). 266–274. 12 indexed citations
9.
10.
Aagaard, Lise & Ebba Holme Hansen. (2013). Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011. BMC Pharmacology and Toxicology. 14(1). 30–30. 23 indexed citations
11.
Andersen, Stig Ejdrup, et al.. (2012). General Practitioners' and Hospital Physicians' Preference for Morphine or Oxycodone as First‐Time Choice for a Strong Opioid: A National Register–Based Study. Basic & Clinical Pharmacology & Toxicology. 112(2). 110–115. 7 indexed citations
12.
Aagaard, Lise, et al.. (2012). Global Patterns of Adverse Drug Reactions Over a Decade. Drug Safety. 35(12). 1171–1182. 105 indexed citations
13.
Aagaard, Lise, et al.. (2011). Adverse Drug Reactions Reported in the German Democratic Republic: A Retrospective Analysis of Reports to the WHO-ADR Database. Research at the University of Copenhagen (University of Copenhagen). 1(2). 60–74. 1 indexed citations
14.
Hansen, Ebba Holme, et al.. (2011). Using text‐mining techniques in electronic patient records to identify ADRs from medicine use. British Journal of Clinical Pharmacology. 73(5). 674–684. 78 indexed citations
15.
16.
Aagaard, Lise, Steffen Thirstrup, & Ebba Holme Hansen. (2009). Opening the white boxes: the licensing documentation of efficacy and safety of psychotropic medicines for children. Pharmacoepidemiology and Drug Safety. 18(5). 401–411. 4 indexed citations
17.
Aagaard, Lise & Ebba Holme Hansen. (2009). Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. PubMed. 9(1). 4–4. 40 indexed citations
18.
Aagaard, Lise, Lars Nielsen, & Ebba Holme Hansen. (2009). Consumer Reporting of Adverse Drug Reactions. Drug Safety. 32(11). 1067–1074. 92 indexed citations
19.
Aagaard, Lise, et al.. (2007). Creating knowledge about adverse drug reactions: A critical analysis of the Danish reporting system from 1968 to 2005. Social Science & Medicine. 65(6). 1296–1309. 16 indexed citations
20.
Aagaard, Lise, et al.. (2007). Knowledge creation about ADRs – turning the perspective from the rear mirror to the projector?. British Journal of Clinical Pharmacology. 65(3). 364–376. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julien Bezin Breakdown of academic impact, for papers by Tom Mjörndal Breakdown of academic impact, for papers by Elliot G. Brown Breakdown of academic impact, for papers by Sue Wood Breakdown of academic impact, for papers by James P. Wilson Breakdown of academic impact, for papers by Lolkje de Jong‐van den Berg Breakdown of academic impact, for papers by Faizan Mazhar Breakdown of academic impact, for papers by Emmanuelle Bondon‐Guitton Breakdown of academic impact, for papers by Linda Härmark Breakdown of academic impact, for papers by Anneke Passier
Rankless by CCL
2026